Mary P. Kearney
- Infectious Diseases top 5%
- Epidemiology top 10%
- Applied Microbiology and Biotechnology top 0.5%
- Clinical Biochemistry top 1%
- General Health Professions top 10%
- Co-authors
- Michael ScottJames C. McElnayMamoon A. AldeyabFidelma A. MageeFeras Darwish ElhajjiYaser M. AlahmadiCarmel HughesMotasem Aldiab
- Topics
- Antibiotic Use and Resistance (12 papers)Antimicrobial Resistance in Staphylococcus (9 papers)Bacterial Identification and Susceptibility Testing (6 papers)
- Journals
- Antimicrobial Agents and ChemotherapyJournal of the American Geriatrics SocietyEmerging infectious diseases
- Partner nations
- United KingdomJordanSwitzerland
In The Last Decade
Mary P. Kearney
25 papers receiving 959 citations
Peers
Comparison fields: 5 of 83
- Infectious Diseases 405
- Epidemiology 398
- Applied Microbiology and Biotechnology 376
- Clinical Biochemistry 294
- General Health Professions 177
Countries citing papers authored by Mary P. Kearney
This map shows the geographic impact of Mary P. Kearney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary P. Kearney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary P. Kearney more than expected).
Fields of papers citing papers by Mary P. Kearney
This network shows the impact of papers produced by Mary P. Kearney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary P. Kearney. The network helps show where Mary P. Kearney may publish in the future.
Co-authorship network of co-authors of Mary P. Kearney
This figure shows the co-authorship network connecting the top 25 collaborators of Mary P. Kearney. A scholar is included among the top collaborators of Mary P. Kearney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary P. Kearney. Mary P. Kearney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 4 | |
| 3 | 23 | |
| 4 | 10 | |
| 5 | 15 | |
| 6 | 24 | |
| 7 | 117 | |
| 8 | 44 | |
| 9 | 21 | |
| 10 | 160 | |
| 11 | 85 | |
| 12 | 43 | |
| 13 | 32 | |
| 14 | 56 | |
| 15 | 59 | |
| 16 | 116 | |
| 17 | 29 | |
| 18 | 1 | |
| 19 | 33 | |
| 20 | 22 |
About Mary P. Kearney
Mary P. Kearney is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Critical Care and Intensive Care Medicine, having authored 26 papers that have together received 999 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (12 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Bacterial Identification and Susceptibility Testing (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (376 citations), Clinical Biochemistry (294 citations) and Molecular Medicine (151 citations). Mary P. Kearney has collaborated with scholars based in United Kingdom, Jordan and Switzerland. Frequent co-authors include Michael Scott, James C. McElnay, Mamoon A. Aldeyab, Fidelma A. Magee, Feras Darwish Elhajji, Yaser M. Alahmadi, Carmel Hughes, Motasem Aldiab, D.F. Gilpin and Michael M. Tunney. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of the American Geriatrics Society and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.